India fights to protect its traditional home remedies
Women look at herbs and medicinal plants at the Ayurvedic fair in Hyderabad. Traditional knowledge, used for centuries by indigenous communities under local laws and customs, plays an important role in areas such as food security, biodiversity, agriculture and medicine.
For centuries, Indian housewives have used homemade remedies based on cow's milk to cure constipation—but in 2009 Swiss giant Nestle applied for a patent to protect a similar product of its own.
Earlier this year, India successfully fought off Nestle's attempt at the European Patent Office (EPO) to secure a patent, saying that using cow's milk as a laxative was mentioned in ancient texts and was therefore not new.
Indian government officials are fighting hundreds of other cases to try to protect the country's "genetic heritage", a topic high on the agenda at the UN's Convention on Biological Diversity currently meeting in Hyderabad.
"India is one of the mega centres for biodiversity in the world," said Vinod Bhatt, director of research at Navdanya, a non-profit body that seeks to promote indigenous knowledge.
"We cannot allow theft of our traditional knowledge that dates back thousands of years and is rooted in our culture. We have to protect ourselves from commercial exploitation by the Western world," Bhatt told AFP.
Traditional knowledge, used for centuries by indigenous communities under local laws and customs, plays an important role in areas such as food security, biodiversity, agriculture and medicine.
"Nestle is just one case. We have already succeeded in 110, and 800 more are in the pipeline," said Vinod Kumar Gupta, the head of India's Traditional Knowledge Digital Library (TKDL).
The library is a digital database established in 2001 to record 250,000 traditional formulations, including the Hindu "ayurvedic" system of medicine that has become hugely popular in the West.
"Every known medicinal plant in India is under piracy attack," said Gupta, citing an example where a US patent application was made by Britain-based firm Provexis on the use of banana extracts as treatment for diarrhoea.
Evidence from the TKDL proved the banana preparation was previously well-known, and the application was withdrawn.
In the cow's milk case, the European patent authorities also sought advice from the database, which confirmed it was a remedy—often mixed with other ingredients—to treat constipation for hundreds of years.
A patent application is normally rejected if there is "prior existing knowledge" about the product, but that is far easier to prove if the information is published in a journal or on a database, rather than only held in folklore.
Some 200 researchers took eight years to create the TKDL database, combing through Hindi, Sanskrit, Arabic, Persian and Urdu texts on ayurveda, yoga and other less-known health systems such as unani and siddha.
The TKDL is accessible to foreign patent offices, which can consult it before deciding whether to grant exclusive rights to applicants.
India woke up to the threat of what is now termed "bio-piracy" 20 years ago after a European patent was granted to a US group on an anti-fungal product derived from the native Indian "neem" tree.
A man holds a Stevia herbal plant and products at the Ayurvedic fair in Hyderabad. The practical effect of patents may in reality have little impact in villages of India, where plants, trees and other natural products are still used to treat maladies.Outraged campaigners and Green Party politicians in Europe challenged its validity, and India finally won a 10-year legal battle in 2000 to have the patent revoked as neem seeds had been used for centuries as a medicine, insecticide and contraceptive.
In 2009, the EPO also withdrew another patent granted to a Spanish company for the use of melon extract to treat the skin disease vitiligo on the same legal grounds.
The practical effect of patents may in reality have little impact in villages of India, where plants, trees and other natural products are still widely used to treat maladies.
But the patents provoke an angry response from the government, which sees protecting knowledge of traditional Indian medicine from foreign commercial exploitation as a matter of national pride.
Legal battles between the TKDL and global firms over patent requests can take years to resolve and require exhaustive documentation by the agency's researchers to prove prior art references.
"We don't see any short-term problems of bio-piracy but we've got to be watchful of the long-term implications," said Bhatt of Navdanya.
Scientists and lawyers agree countries such as India must be more vigilant.
"Between 1992 and 2000 China revised its patent laws twice to ensure that it could draw intellectual property control over its unique system of medicine," Devinder Sharma, an agriculture scientist and biodiversity expert, told AFP.
He said similar legislation must be put in place in India.
"Instead of chasing 'bio-pirates' here and there, we could rest easy in the knowledge that we are legally protected," he said.
Lawyers backed Sharma's idea and called for comprehensive laws to provide better protection from the international patents.
"Traditional knowledge falls into the grey area and is not as clearly defined as intellectual property rights in Indian law," Pratiush Pratik, a New Delhi-based lawyer who specialises in the subject, told AFP.
Western societies have accepted the loss of traditional knowledge, he said. "India must not make that mistake."
(c) 2012 AFP
- Patenting melon juice? Not if India gets its way... Dec 11, 2009 | not rated yet | 0
- Patent fight in India centers on AIDS drug May 11, 2006 | not rated yet | 0
- India's patent laws under pressure: The Lancet special report Sep 10, 2012 | not rated yet | 0
- Bayer challenges India cancer drug ruling May 06, 2012 | not rated yet | 0
- India generics giant wins cancer drug patent case Sep 08, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Medications 14 hours ago | not rated yet | 0
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications May 23, 2013 | 1 / 5 (1) | 0
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications May 23, 2013 | 5 / 5 (1) | 0
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications May 22, 2013 | not rated yet | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
14 hours ago | 5 / 5 (2) | 5
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
6 hours ago | not rated yet | 1
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
14 hours ago | not rated yet | 1
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
14 hours ago | not rated yet | 0
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
May 20, 2013 | 4.8 / 5 (30) | 9 |